Novo Nordisk
Global leader in diabetes and obesity therapeutics.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Recruiting · Overweight
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseasePhase 3 · Recruiting · Sickle Cell Disease
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightPhase 3 · Recruiting · Overweight
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightPhase 3 · Recruiting · Obesity
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaPhase 3 · Recruiting · Obesity
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaPhase 3 · Recruiting · Obesity
Selected patent records
semaglutide · Expires 2026-01-20
US 10376652semaglutide · Expires 2026-01-20
US 9108002semaglutide · Expires 2026-01-20
US 9616180semaglutide · Expires 2026-01-20
US 9861757semaglutide · Expires 2026-01-20
US 8536122semaglutide · Expires 2026-03-20
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/novo-nordisk/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.